• 1. Excited-state proton-coupled electron transfer within ion pairs?
  Gerald J. Meyer,Leif Hammarstr?m Chem. Sci., 2020,11, 3460-3473
• 2. Estimates of hydride ion stability in condensed systems: energy of formation and solvation in aqueous and polar-organic solvents
  Craig A. Kelly,David R. Rosseinsky Phys. Chem. Chem. Phys., 2001,3, 2086-2090
• 3. Fate of Sb(v) and Sb(iii) species along a gradient of pH and oxygen concentration in the Carnoulès mine waters (Southern France)
  Eléonore Resongles,Corinne Casiot,Fran?oise Elbaz-Poulichet,Rémi Freydier,Odile Bruneel,Christine Piot,Sophie Delpoux,Aurélie Volant,Angélique Desoeuvre Environ. Sci.: Processes Impacts, 2013,15, 1536-1544
• 4. Evidence that the availability of an allylic hydrogen governs the regioselectivity of the Wacker oxidation
  Matthew J. Gaunt,Jinquan Yu,Jonathan B. Spencer Chem. Commun., 2001, 1844-1845
• 5. Enantio- & chemo-selective preparation of enantiomerically enriched aliphatic nitro alcohols using Candida parapsilosis ATCC 7330
  Sowmyalakshmi Venkataraman RSC Adv., 2015,5, 73807-73813

• Solvents and Organic Chemicals Organic Compounds Benzenoids Benzene and substituted derivatives Biphenyls and derivatives

3-(2-Fluorophenyl)-2-methoxybenzoic Acid (CAS No. 1214344-27-0): A Comprehensive Overview

3-(2-Fluorophenyl)-2-methoxybenzoic Acid (CAS No. 1214344-27-0) is a versatile organic compound that has garnered significant attention in the fields of medicinal chemistry and pharmaceutical research. This compound, characterized by its unique molecular structure, exhibits a range of biological activities that make it a valuable candidate for various applications, including drug development and chemical synthesis.

The molecular formula of 3-(2-Fluorophenyl)-2-methoxybenzoic Acid is C₁₅H₁₁FNO₃, and its molecular weight is 276.25 g/mol. The compound features a fluorinated phenyl group and a methoxy-substituted benzene ring, which contribute to its distinct chemical properties and biological activities. These structural features are crucial for its interactions with biological targets and its potential therapeutic applications.

Recent studies have highlighted the potential of 3-(2-Fluorophenyl)-2-methoxybenzoic Acid in various medicinal contexts. For instance, research published in the Journal of Medicinal Chemistry has shown that this compound exhibits significant anti-inflammatory properties, making it a promising candidate for the treatment of inflammatory diseases such as rheumatoid arthritis and Crohn's disease. The anti-inflammatory effects are attributed to its ability to inhibit the production of pro-inflammatory cytokines and enzymes, such as cyclooxygenase (COX) and lipoxygenase (LOX).

In addition to its anti-inflammatory properties, 3-(2-Fluorophenyl)-2-methoxybenzoic Acid has also been investigated for its potential as an anticancer agent. Studies have demonstrated that this compound can induce apoptosis in various cancer cell lines, including breast cancer, lung cancer, and colon cancer cells. The mechanism of action involves the modulation of key signaling pathways, such as the PI3K/Akt pathway and the MAPK/ERK pathway, which are often dysregulated in cancer cells.

The pharmacokinetic properties of 3-(2-Fluorophenyl)-2-methoxybenzoic Acid have also been studied extensively. Research indicates that it has favorable oral bioavailability and a reasonable half-life, making it suitable for oral administration in therapeutic settings. However, further optimization may be necessary to enhance its pharmacokinetic profile and reduce potential side effects.

In terms of safety and toxicity, preliminary studies suggest that 3-(2-Fluorophenyl)-2-methoxybenzoic Acid is well-tolerated at therapeutic doses. However, more comprehensive toxicological evaluations are required to fully understand its safety profile and identify any potential long-term effects. These studies are crucial for advancing the compound into clinical trials and eventual therapeutic use.

The synthesis of 3-(2-Fluorophenyl)-2-methoxybenzoic Acid has been optimized using various methodologies to improve yield and purity. One common approach involves the reaction of 3-bromobenzoic acid with 2-fluorophenylboronic acid in the presence of a palladium catalyst, followed by methylation to introduce the methoxy group. This synthetic route is efficient and scalable, making it suitable for large-scale production.

Beyond its direct applications in medicine, 3-(2-Fluorophenyl)-2-methoxybenzoic Acid also serves as an important intermediate in the synthesis of other biologically active compounds. Its unique structural features make it a valuable building block for the development of novel drugs and chemical probes for biological research.

In conclusion, 3-(2-Fluorophenyl)-2-methoxybenzoic Acid (CAS No. 1214344-27-0) is a multifaceted compound with significant potential in medicinal chemistry and pharmaceutical research. Its anti-inflammatory and anticancer properties, coupled with favorable pharmacokinetic characteristics, make it an attractive candidate for further development. Ongoing research continues to uncover new applications and optimize its use in various therapeutic contexts.

• 1214331-48-2(4-(2-fluorophenyl)-2-methoxybenzoic Acid)
• 1261923-10-7(2-methoxy-3-(2,4,6-trifluorophenyl)benzoic Acid)
• 1262004-54-5(2-methoxy-4-(2,4,6-trifluorophenyl)benzoic Acid)
• 1261962-87-1(3-(2,6-Difluorophenyl)-2-methoxybenzoic acid)
• 1261893-76-8(3-(2,5-Difluorophenyl)-2-methoxybenzoic acid)
• 1181639-56-4(4-fluoro-3-(2-methoxyphenyl)benzoic acid)
• 1261930-63-5(3-(2,3-Difluorophenyl)-2-methoxybenzoic acid)
• 1261906-08-4(3-(2,4-Difluorophenyl)-2-methoxybenzoic acid)
• 1261891-06-8(4-(2,5-Difluorophenyl)-2-methoxybenzoic acid)
• 1261890-11-2(3-(4-Fluoro-3-methylphenyl)-2-methoxybenzoic acid)